This article available in Chinese version only

窩輪反將風險降(一)?

2022-07-18

投資者擔心高通脹帶動環球息口高企,不利股市投資,美股反覆偏軟,港股則跌足五日,指數一周內跌逾一千四百點失守多條移動平均線。隨大市重心向下,投資者作兩手準備的同時,不少資金亦陸續場部署個股撈底反彈的機會。截至7月14日的數字,淡倉街貨多的個股為騰訊及比亞迪; 好倉方面,阿里、騰訊及中移為資金流入最多。

 

本周筆者收到投資者問,雖然短線市場不明朗因素仍多,但眼見股價已回落了較大的幅度,若想入場又不想以太多資金冒險,又可如何部署?筆者認為,窩輪的設計正正幫到投資者達到減少成本管控風險的作用。

 

不少人一聽到窩輪,便會認為是高風險的投資,又怎能用以控制風險?豈不是要冒上更大的市場風險?

 

的確,窩輪作為一期權投資工具,特點是有槓桿效應,比對買入同等金額的正股,所要面對的風險與回報亦以槓桿式放大。理論上,若相關資產價格及波幅走勢一致,好倉方面跟正股一樣,回報沒有設上限,而淡倉方面,因為正股股價理輪上最低是零,所以理輪上淡倉價格將會有上限。相反,若正股價格或波幅走勢相反,雖然有同樣的槓桿效應,但最大的損失僅為投入的本金,沒有被追收補倉的風險。

 

因此,不少投資者其實會利用窩輪槓杆,將資金量大幅減少,即使是最壞的情況,損失亦較投放於正股的資金量為少,達致保障絕大部分現金實力的目的。

Hot topics
Back to Hot topics
本結構性產品並無抵押品,如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。

本文由香港上海匯豐銀行有限公司(「本行」或「發行商」)發行(包括任何參考條款),僅供參考之用,並不構成邀約、游說、或建議出售或購買結構性產品。

結構性產品屬複雜產品,投資者務須就此審慎行事,除非投資者完全了解及願意承擔所涉風險,否則切勿投資此產品。結構性產品價格可急升可急跌,投資者或會損失所有或大部分投資。過往表現並不反映將來表現。投資前應了解結構性產品之性質及風險,並詳閱有關上市文件,獨立決定是否適合自己,若需要應諮詢專業建議。本行及其委任之流通量提供者可能是結構性產品的唯一市場參與者,而結構性產品的二級市場可能有限。謹請注意,牛熊證設有強制收回機制,因此有可能提早終止,在此情況下(i)N類牛熊證投資者會損失於牛熊證的全部投資;而(ii)R類牛熊證之剩餘價值則可能為零。買賣與美國指數掛鈎的結構性產品可能帶有額外風險,包括:(a)與交易日和交易時間差異有關的風險;(b) 有關指數的公開資料較少,或未有提供中文版本;(c) 與指數有關的政治和經濟風險(例如美國);(d) 匯率風險; (e) 可能延遲結算及(f) 在成份股並無交易時公佈指數水平與MSCI中國A50互聯互通指數掛鈎的衍生權證投資者可能會承受額外風險,包括:(i) 新推出指數的風險;(ii) 指數成份股為透過滬港通及/或深港通在滬港通及深港通的北向交易渠道買賣的A股;(iii) 有關指數的公開資料較少,且該等資料或未有提供中文版本;(iv) 與指數有關的政治及經濟風險;(v) 匯率風險;及(vi) 人民幣利率風險。

作者為金管局及證監會持牌人士,並無就結構性產品或相關資產持有任何直接或間接權益。
Sign up to our newsletter

Stay abreast of the trends with the latest investment insight and market updates.

Latest article

(Available in Chinese only)
Back to Hot topics

Important Risk Warning

The structured products are not collateralized. If the issuer is insolvent or defaults, investors may not recover part or all of the amount due.

Structured products are complex products. Investors should exercise caution in relation to them. The price of the structured products may fall in value as rapidly as it may rise and investors may sustain a total or substantial loss of their investment. Prospective investors should ensure that they understand the nature and risks and seek professional advice where applicable. Please also note that CBBCs have a mandatory call feature and may therefore be subject to early termination, upon which (i) investors in category N CBBCs will lose all of their investments in the CBBCs; and (ii) the residual value of category R CBBCs may be zero. Inline warrants have been newly introduced to the market and there are no similar products currently listed on the Stock Exchange of Hong Kong Limited for comparison. Inline warrants carry exotic features, and their terms and pricing may be more complicated than standard derivative warrants. Maximum potential payoff is fixed and capped. Price movement of the inline warrants may be disproportionate or opposite to the price movement of the underlying asset. Trading structured products with United States (US) underlying index may be exposed to additional risks, including (a) risks relating to difference in trading days and hours, (b) less public information about the index and such information may not be available in Chinese, (c) political and economic risks relating to the index regions (such as the US), (d) exchange rate risks, (e) possible delay in settlement, and (f) publication of index level when component shares are not trading. Investors in derivative warrants linked to the MSCI China A 50 Connect Index may be exposed to additional risks, including (i) risk for newly launched index, (ii) the index constituents are A-shares traded under the Northbound Stock Connect channel through Shanghai-Hong Kong Stock Connect and/or Shenzhen-Hong Kong Stock Connect, (iii) less public information about the index and such information may not be available in Chinese, (iv) political and economic risks relating to the index, (v) exchange rate risks, and (vi) Renminbi interest rate risks. Click here for "Terms of Use".

Disclaimer

By viewing this website or using any information or functions of this website, you are deemed to acknowledge that you agree to the Privacy and Security, Terms of Use and Hyperlink Policy. Click here for "Disclaimer".

All data/charts are for reference purposes only.